Bon Natural Life Ltd(BON) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 15 at 4:00 PM ET (Korea 10/16 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.3 | Insider Own | 26.47% | Shs Outstand | 6.1M | Perf Week | -4.04% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 6.0M | Perf Month | -0.88% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 0.48% | Short Float | 0.2% | Perf Quarter | -3.45% |
| Income | -0.01B | P/S | 0.49 | EPS this Y | - | Inst Trans | 0.89% | Short Ratio | 1.35 | Perf Half Y | -13.85% |
| Sales | 0.02B | P/B | 0.18 | EPS next 5Y | - | ROA | -14.98% | Short Interest | 0.01M | Perf YTD | -29.56% |
| Book/sh | 6.22 | P/C | 1 | EPS past 3/5Y | - | ROE | -21.79% | 52W High | -51.93% ($2.33) | Perf Year | -49.09% |
| Cash/sh | 1.12 | P/FCF | 4.16 | Sales past 3/5Y | -14.54% 0.49% | ROIC | -21.71% | 52W Low | 17.89% ($0.95) | Perf 3Y | -98.91% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -173.3% | Gross Margin | 22.1% | Volatility(W/M) | 3.5% 6% | Perf 5Y | -99.93% |
| Dividend TTM | - | EV/Sales | 0.65 | Sales Y/Y TTM | -12.92% | Oper. Margin | -45.5% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.31 | EPS Q/Q | -400.04% | Profit Margin | -60.39% | RSI (14) | 41.53 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.83 | Sales Q/Q | 1.86% | SMA20 | -4.6% ($1.17) | Beta | -0.23 | Target Price | - |
| Payout | - | Debt/Eq | 0.24 | Earnings | - | SMA50 | -2.65% ($1.15) | Rel Volume | 0.96 | Prev Close | $1.13 |
| Employees | 96 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | - | SMA200 | -15.59% ($1.33) | Avg Volume(3M) | 0.01M | Price | $1.12 |
| IPO | 2021/6/24 | Option/Short | No/Yes | Trades | 17 | Volume | 8,342 | Change | -0.88% |
🌿 Bon Natural Life () is a natural and healthcare ingredient company based in Xi'an, China, that supplies plant-derived fragrance compounds, health-functional powdered beverages, and bioactive food ingredients. Its core portfolio includes cosmetic-grade natural compounds such as Sclareolide and Ambroxide, Stachyose-based prebiotics, and apple polyphenol-centered metabolic health products. The company has also recently disclosed its entry into a new drug R&D business that combines a traditional Chinese medicine (TCM) natural compound library with AI.
Over the past 1 year, on the lower side
52% below its 1-year high.
Traded about as much as usual. That is 96% of its average volume.
BON has a sound balance sheet but weak earning power
Of every $100 in sales, $45.50 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $49. Peers typically go for $146.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.9%. The S&P 500 did +73% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
BND Vanguard Total Bond Market ETF 163.2B 
AGG iShares Core U.S. Aggregate Bond ETF 137.7B 
SGOV iShares 0-3 Month Treasury Bond ETF 115.7B 
BNDX Vanguard Total International Bond ETF 83.7B 
VCIT Vanguard Intermediate-Term Corporate Bond ETF 66.7B It ranks #58 of 62 in the industry
Based on market cap of $9M.
LOOP#57 Loop Industries Inc $19M PER - BON#58 Bon Natural Life Ltd $9M PER - 
YMAT#59 J-Star Holding Co Ltd $6M PER - 
SNES#60 SenesTech Inc $4M PER - 
BGLC#61 BioNexus Gene Lab Corp $4M PER - 
FAQ
What kind of company is BON?
BON belongs to the Basic Materials sector and operates in the Specialty Chemicals industry.
What is the market cap of BON?
The market cap of BON is approximately $9M, ranking 5,481 within its sector.
What is the 52-week high and low for BON?
BON has recorded a 52-week high of $2.33 and a low of $0.95.
